CHEK
Price
$0.66
Change
+$0.01 (+1.54%)
Updated
Sep 5, 04:54 PM (EDT)
Capitalization
3.92M
79 days until earnings call
MYNZ
Price
$1.61
Change
-$0.07 (-4.17%)
Updated
Sep 5, 04:51 PM (EDT)
Capitalization
7.46M
68 days until earnings call
Interact to see
Advertisement

CHEK vs MYNZ

Header iconCHEK vs MYNZ Comparison
Open Charts CHEK vs MYNZBanner chart's image
Check-Cap
Price$0.66
Change+$0.01 (+1.54%)
Volume$150
Capitalization3.92M
Mainz Biomed
Price$1.61
Change-$0.07 (-4.17%)
Volume$951
Capitalization7.46M
CHEK vs MYNZ Comparison Chart in %
Loading...
CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHEK vs. MYNZ commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHEK is a Hold and MYNZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CHEK: $0.67 vs. MYNZ: $1.63)
Brand notoriety: CHEK and MYNZ are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CHEK: 26% vs. MYNZ: 18%
Market capitalization -- CHEK: $3.92M vs. MYNZ: $7.46M
CHEK [@Medical Specialties] is valued at $3.92M. MYNZ’s [@Medical Specialties] market capitalization is $7.46M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHEK’s FA Score shows that 1 FA rating(s) are green whileMYNZ’s FA Score has 1 green FA rating(s).

  • CHEK’s FA Score: 1 green, 4 red.
  • MYNZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both CHEK and MYNZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHEK’s TA Score shows that 6 TA indicator(s) are bullish while MYNZ’s TA Score has 6 bullish TA indicator(s).

  • CHEK’s TA Score: 6 bullish, 3 bearish.
  • MYNZ’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CHEK is a better buy in the short-term than MYNZ.

Price Growth

CHEK (@Medical Specialties) experienced а -8.71% price change this week, while MYNZ (@Medical Specialties) price change was -2.98% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

Reported Earning Dates

CHEK is expected to report earnings on Nov 24, 2025.

MYNZ is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MYNZ($7.46M) has a higher market cap than CHEK($3.92M). CHEK YTD gains are higher at: -34.488 vs. MYNZ (-61.111). CHEK has more cash in the bank: 1.08M vs. MYNZ (978K). CHEK has less debt than MYNZ: CHEK (0) vs MYNZ (8.27M).
CHEKMYNZCHEK / MYNZ
Capitalization3.92M7.46M53%
EBITDAN/AN/A-
Gain YTD-34.488-61.11156%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash1.08M978K110%
Total Debt08.27M-
FUNDAMENTALS RATINGS
CHEK: Fundamental Ratings
CHEK
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CHEKMYNZ
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIEN116.9222.10
+23.31%
Ciena Corp
GSIW0.10N/A
+4.27%
Garden Stage Limited
CPRI21.760.64
+3.03%
Capri Holdings Limited
ATLX5.100.13
+2.62%
Atlas Lithium Corp
ASIX21.040.33
+1.59%
AdvanSix

CHEK and

Correlation & Price change

A.I.dvisor tells us that CHEK and IINN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHEK and IINN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEK
1D Price
Change %
CHEK100%
-3.92%
IINN - CHEK
29%
Poorly correlated
-3.42%
MYNZ - CHEK
27%
Poorly correlated
+1.20%
SENS - CHEK
25%
Poorly correlated
-0.88%
NVNO - CHEK
23%
Poorly correlated
+1.12%
UFPT - CHEK
21%
Poorly correlated
+2.57%
More

MYNZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
+1.20%
ACRS - MYNZ
40%
Loosely correlated
+0.49%
CHEK - MYNZ
27%
Poorly correlated
-3.92%
STXS - MYNZ
25%
Poorly correlated
+1.85%
SINT - MYNZ
23%
Poorly correlated
-17.36%
BLFS - MYNZ
23%
Poorly correlated
+3.31%
More